Categories: Business

J&J strikes $2.2 billion buyout deal for eye disease biotech Ollin Biosciences

Nov 16 (Reuters) – Johnson & Johnson said on Monday it had agreed to buy Texas-based biotech Ollin Biosciences, expanding its pipeline of eye disease therapies. Johnson & Johnson will acquire Ollin

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

BRIEF-Megatherm Induction Announces Transformer Division Expansion Project Including 220 KV And Cast Resin Types

Nov 16 (Reuters) - Megatherm Induction Ltd: * ANNOUNCES TRANSFORMER DIVISION EXPANSION PROJECT INCLUDING 220…

1 second ago

Trump's Nvidia stake grew to as much as $62 million, Washington Post reports

Nov 16 (Reuters) - US President Donald Trump's reported trades this year suggest he held…

3 minutes ago

UK authorities investigating after Russell Brand's message from prison

LONDON, Nov 16 (Reuters) - British authorities are investigating whether Russell Brand, the comedian found…

5 minutes ago

AUSTRIA'S FORMER FOREIGN MINISTER KARIN KNEISSL SAYS THAT AUSTRIAN AUTHORITIES HAD INITIATED PROCEEDINGS TO REVOKE HER CITIZENSHIP – TASS

AUSTRIA'S FORMER FOREIGN MINISTER KARIN KNEISSL SAYS THAT AUSTRIAN AUTHORITIES HAD INITIATED PROCEEDINGS TO REVOKE…

7 minutes ago

BRIEF-Fredrik Geijer Steps Down As CFO Of Gaming Corps

Nov 16 (Reuters) - Gaming Corps AB: * FREDRIK GEIJER STEPS DOWN AS CFO OF…

11 minutes ago